Target intelligence / Profile preview

HTH-type transcriptional repressor LfrR (LfrR)

Target
LfrR
Molecular classification
Transcription factor, TetR family repressor, HTH-type transcriptional repressor
01

Overview

HTH-type transcriptional repressor LfrR is a member of the TetR family of regulators, primarily identified and characterized in Mycobacterium smegmatis [1, 2]. It serves as the primary negative regulator of the lfrRA operon, which encodes the LfrA multidrug efflux pump, a major facilitator superfamily (MFS) transporter [2, 4]. In the absence of inducing signals, LfrR homodimers bind to a specific operator sequence in the promoter region, sterically hindering RNA polymerase and repressing transcription [2, 3]. This repression is relieved when LfrR binds to various small-molecule ligands, such as cationic dyes (e.g., ethidium bromide, acriflavine, proflavine) and certain antibiotics like fluoroquinolones [2, 3]. Ligand binding induces a conformational change that reduces the protein's affinity for DNA, leading to the overexpression of the LfrA pump and subsequent extrusion of toxic compounds from the cell [3, 4]. As a key mediator of intrinsic multidrug resistance in mycobacteria, LfrR is a significant target for studying bacterial adaptation and developing strategies to sensitize pathogens to existing antibiotics [1, 2]. Structural studies have revealed that LfrR possesses a high degree of conformational plasticity, allowing it to recognize a broad range of structurally diverse ligands [3]. Mutations in the lfrR gene can lead to constitutive expression of the efflux pump, further enhancing the multidrug-resistant phenotype of the bacteria [2]. Understanding the regulatory network of LfrR provides insights into the evolution of antibiotic resistance in clinically relevant mycobacteria like Mycobacterium tuberculosis [1, 4].

Other names
MSMEG_6223TetR family transcriptional repressor LfrRLfrRA repressor
02

Mechanism of action

Ligand-induced dissociation from DNA leading to the induction of the LfrA multidrug efflux pump

03

Biological functions

Transcription regulationAntibiotic resistanceEfflux pump regulationResponse to toxic substances
04

Disease associations

Infection
05

Safety considerations

Redundancy of bacterial efflux systemsPotential for compensatory mutations in other regulatorsLimited therapeutic window due to specificity to certain mycobacteria
06

Interacting drugs

Acriflavine

5 more in the full profile.

07

Biomarkers

lfrA mRNA expression levelslfrR gene mutations

Beyond the preview

Go deeper on HTH-type transcriptional repressor LfrR (LfrR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HTH-type transcriptional repressor LfrR (LfrR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call